2nd COVID-19 vaccine trial paused
over unexplained illness
|
A late-stage
study of Johnson & Johnson's COVID-19 vaccine candidate has been paused
while the company investigates whether a study participant's "unexplained
illness" is related to the shot. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Tuesday, October 13, 2020
2nd COVID-19 vaccine trial paused over unexplained illness
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment